l-carnitine, a friend or foe for cardiovascular disease? A Mendelian randomization study

Jie V. Zhao,Stephen Burgess,Bohan Fan,C. Mary Schooling
DOI: https://doi.org/10.1186/s12916-022-02477-z
IF: 9.3
2022-09-03
BMC Medicine
Abstract:l -carnitine is emerging as an item of interest for cardiovascular disease (CVD) prevention and treatment, but controversy exists. To examine the effectiveness and safety of l -carnitine, we assessed how genetically different levels of l -carnitine are associated with CVD risk and its risk factors. Given higher CVD incidence and l -carnitine in men, we also examined sex-specific associations.
medicine, general & internal
What problem does this paper attempt to address?